Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 3, 2010, Pages 271.e1-271.e5

  Sep, Simone ^a   Verbeek, Jef ^a   Koek, Gerardus ^a   Smits, Luc ^a   Spaanderman, Marc ^b   Peeters, Louis ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

comparative study; HELLP syndrome; pathogenesis; preeclampsia

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HELLP SYNDROME; HEMODYNAMICS; HEMOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OBESITY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEINURIA; PUERPERIUM; THROMBOPHILIA;

EID: 77649188231     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.10.874     Document Type: Article

References (23)

1. Sibai B.M. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 105 (2005) 402-410
2. Gilbert J.S., Nijland M.J., and Knoblich P. Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections. Expert Rev Cardiovasc Ther 6 (2008) 1367-1377
3. Buimer M., Keijser R., Jebbink J.M., et al. Seven placental transcripts characterize HELLP-syndrome. Placenta 29 (2008) 444-453
4. Leeners B., Rath W., Kuse S., Irawan C., Imthurn B., and Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin Sci (Colch) 111 (2006) 81-86
5. Barton J.R., and Sibai B.M. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 112 (2008) 359-372
6. Report of the national high blood pressure education program: working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
7. The Netherlands Perinatal Registry. Bilthoven: NPR-foundation. http://www.perinatreg.nl/ Accessed April 22, 2009
8. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement; executive summary. Cardiol Rev 13 (2005) 322-327
9. Spaanderman M.E., Ekhart T.H., van Eyck J., Cheriex E.C., de Leeuw P.W., and Peeters L.L. Latent hemodynamic abnormalities in symptom-free women with a history of preeclampsia. Am J Obstet Gynecol 182 (2000) 101-107
10. Fagard R.H., Pardaens K., Staessen J.A., and Thijs L. The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol 38 (2001) 227-231
11. Noris M., Perico N., and Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 1 (2005) 98-114 quiz 120
12. Haddad B., Barton J.R., Livingston J.C., Chahine R., and Sibai B.M. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 183 (2000) 444-448
13. Osmanagaoglu M.A., Erdogan I., Zengin U., and Bozkaya H. Comparison between HELLP syndrome, chronic hypertension, and superimposed preeclampsia on chronic hypertension without HELLP syndrome. J Perinat Med 32 (2004) 481-485
14. Gul A., Cebeci A., Aslan H., Polat I., Ozdemir A., and Ceylan Y. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest 59 (2005) 113-118
15. Diedrich F., Renner A., Rath W., Kuhn W., and Wieland E. Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation. Am J Obstet Gynecol 185 (2001) 166-172
16. van Runnard Heimel P.J., Kavelaars A., Heijnen C.J., et al. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens Pregnancy 27 (2008) 253-265
17. O'Brien J.M., Milligan D.A., and Barton J.R. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 183 (2000) 921-924
18. Matchaba P., and Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 1 (2004) CD002076
19. Vinnars M.T., Wijnaendts L.C., Westgren M., Bolte A.C., Papadogiannakis N., and Nasiell J. Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension 51 (2008) 1295-1299
20. Martin Jr. J.N., May W.L., Rinehart B.K., Martin R.W., and Magann E.F. Increasing maternal weight: a risk factor for preeclampsia/eclampsia but apparently not for HELLP syndrome. South Med J 93 (2000) 686-691
21. Kujovich J.L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 191 (2004) 412-424
22. Sailhamer E.A., Li Y., Smith E.J., et al. Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 144 (2008) 204-216
23. Brozna J.P. Shwartzman reaction. Semin Thromb Hemost 16 (1990) 326-332